JD Health (06618) Launches Evidence-Based Medical AI Product "Zhiyi" to Support Doctors in Clinical and Research Settings

Stock News
01/17

On January 17, the 2026 JD Health Annual Doctor Summit was grandly held in Beijing. At the event, JD Health significantly launched "Zhiyi," an evidence-based medical AI product specifically designed for doctors. According to the introduction, this product focuses on two core scenarios: clinical decision-making and academic research, deeply integrating tens of millions of authoritative global medical data points. It can rapidly screen and highly synthesize vast amounts of authoritative literature and guidelines, directly outputting actionable conclusions to enhance the quality and efficiency of doctors' clinical diagnosis and treatment, while providing robust support for scientific research exploration. It is reported that "Zhiyi" will be fully integrated into the JD Doctor APP and made available for all doctors to experience; regardless of whether they are affiliated with JD Internet Hospital, they can utilize this evidence-based medical AI product.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10